Who have Metastases to bone when taking Keflex and Zometa - from FDA reports
Metastases to bone is found among people who take Keflex and Zometa, especially for people who are female, 50-59 old , have been taking the drugs for 2 - 5 years, also take medication Aredia, and have Pain. This review analyzes which people have Metastases to bone with Keflex and Zometa. It is created by eHealthMe based on reports of 750 people who have side effects when taking Keflex and Zometa from FDA, and is updated regularly.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.
750 people reported to have side effects when taking Keflex and Zometa. Among them, 259 people (34.53%) have Metastases to bone
Number of reports submitted per year:
Time on the drugs when people have metastases to bone *:
- < 1 month: 1.6400000000000001 %
- 1 - 6 months: 6.5600000000000005 %
- 6 - 12 months: 13.11 %
- 1 - 2 years: 26.23 %
- 2 - 5 years: 52.46 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have metastases to bone when taking the drugs *:
- female: 76.31 %
- male: 23.69 %
Age of people who have metastases to bone when taking th drugs *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 1.08 %
- 20-29: 0.54 %
- 30-39: 2.15 %
- 40-49: 19.89 %
- 50-59: 43.01 %
- 60+: 33.33 %
Top conditions involved for these people *:
- Pain: 25 people, 9.65%
- Depression: 24 people, 9.27%
- Metastasis (spreadable cancer to other organ from origin): 20 people, 7.72%
- Prostate Cancer: 17 people, 6.56%
- Metastatic Neoplasm (spreadable cancer tumour): 17 people, 6.56%
Top co-used drugs for these people *:
- Aredia: 127 people, 49.03%
- Faslodex: 103 people, 39.77%
- Xanax: 90 people, 34.75%
- Taxotere: 88 people, 33.98%
- Lasix: 87 people, 33.59%
Top other side effects for these people *:
- Osteonecrosis Of Jaw (death of bone of jaw): 229 people, 88.42%
- Pain: 225 people, 86.87%
- Stress And Anxiety: 197 people, 76.06%
- Bone Disorder: 166 people, 64.09%
- Back Pain: 165 people, 63.71%
* Approximation only. Some reports may have incomplete information.
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Drugs that are associated with Metastases to boneMetastases to bone
Could your condition cause Metastases to boneMetastases to bone
Related publications that referenced our studies
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
Recent general studies
- Diamox and Azithromycin drug interaction - 2 seconds ago
- Gabitril and Invirase drug interaction - 2 seconds ago
- Will you have Fasting with Fish Oil? - 3 seconds ago
- Will you have Weight Loss Poor with Belsomra? - 3 seconds ago
- Will you have Weight Loss - Intentional with Belsomra? - 3 seconds ago
Recent personal studies
- A study for a 18 year old girl who takes Keflex - an hour ago
- A study for a 58 year old man who takes Otezla - 2 hours ago
- A study for a 12 year old girl who takes Vyvanse, Lexapro - 3 hours ago
- A study for a 63 year old man who takes Losartan, Zocor - 4 hours ago
- A study for a 36 year old woman who takes Atarax - 4 hours ago
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.